The Pressure Is On For 340B Entities

Law360, New York (March 4, 2013, 11:18 AM EST) -- The 340B drug pricing program was created in 1992. Named after the enacting statutory provision, through the 340B program, pharmaceutical manufacturers provide discounted outpatient prescription drugs to qualifying safety net providers serving uninsured and indigent patients.

The 340B program is administered by the federal Health Resources and Services Administration (HRSA) which, until recently, took a hands-off approach to 340B program oversight. But things are rapidly changing, and 340B entities are under increasing scrutiny.

Multiple factors have converged to impact the 340B program, including:

Expansion of the...
To view the full article, register now.